Judge Again Tosses Abbott Patent For Inequitable Conduct
A California district court on Tuesday ruled again that Abbott Laboratories' patent covering blood glucose monitoring technology was unenforceable, finding that an Abbott attorney and a scientist committed inequitable conduct by...To view the full article, register now.
Already a subscriber? Click here to view full article